Stock seems to have following the Trendline as given. There has been 4 touches so far on this trendline, indicating a strong Support formation.
If the stock continues to obey the trendline, it could revisit its Swing High again.
MACD Crossover also indicates a good bullish momentum.
While there us a Support formed at 4748 level, even our Trendline intersects at the same region in the coming weeks. So if you want a better entry, you can wait for a retest at the Trendline again and then take an entry based on your Risk Management.
If the stock continues to obey the trendline, it could revisit its Swing High again.
MACD Crossover also indicates a good bullish momentum.
While there us a Support formed at 4748 level, even our Trendline intersects at the same region in the coming weeks. So if you want a better entry, you can wait for a retest at the Trendline again and then take an entry based on your Risk Management.
Note
Positive News: LTIMindtree Delivers 2.6% QoQ USD Revenue Growth in CC.Company also reported a bigger-than-expected rise in first-quarter revenue, snapping five straight quarters of slowing growth, aided by growth in its manufacturing and technology, media & communications (TMT) segments.
Also Q1 CONSOL NET PROFIT 11.35 BILLION RUPEES; IBES PROFIT EST. 11.64 BILLION RUPEES
Trade closed: target reached
Trade Completed. Target Achieved.Total 16% Profits booked.
Time Taken = 10 weeks.
Congrats to those who made good profits with this Trade.
This is how perfectly Price Action can mint you money when done right.
Trade can still be held on based on your Risk Management as the momentum still looks strong and it is possible that the Stock can go further upward.
Follow for more such Ideas!
Comment any Stock that you want me to take a look into and share insights.
Kudos!!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.